135 related articles for article (PubMed ID: 37796679)
1. TP53 Mutations in Esophageal Squamous Cell Carcinoma.
Zhong L; Li H; Chang W; Ao Y; Wen Z; Chen Y
Front Biosci (Landmark Ed); 2023 Sep; 28(9):219. PubMed ID: 37796679
[TBL] [Abstract][Full Text] [Related]
2. Mutant TP53 G245C and R273H promote cellular malignancy in esophageal squamous cell carcinoma.
Kang N; Wang Y; Guo S; Ou Y; Wang G; Chen J; Li D; Zhan Q
BMC Cell Biol; 2018 Aug; 19(1):16. PubMed ID: 30126368
[TBL] [Abstract][Full Text] [Related]
3. PRIMA-1 induces p53-mediated apoptosis by upregulating Noxa in esophageal squamous cell carcinoma with TP53 missense mutation.
Furukawa H; Makino T; Yamasaki M; Tanaka K; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
Cancer Sci; 2018 Feb; 109(2):412-421. PubMed ID: 29168598
[TBL] [Abstract][Full Text] [Related]
4. Mutant p53 activates hnRNPA2B1-AGAP1-mediated exosome formation to promote esophageal squamous cell carcinoma progression.
Feng R; Yin Y; Wei Y; Li Y; Li L; Zhu R; Yu X; Liu Y; Zhao Y; Liu Z
Cancer Lett; 2023 May; 562():216154. PubMed ID: 37030635
[TBL] [Abstract][Full Text] [Related]
5. CircCNTNAP3-TP53-positive feedback loop suppresses malignant progression of esophageal squamous cell carcinoma.
Wang H; Song X; Wang Y; Yin X; Liang Y; Zhang T; Xu L; Jiang F; Dong G
Cell Death Dis; 2020 Nov; 11(11):1010. PubMed ID: 33239613
[TBL] [Abstract][Full Text] [Related]
6.
Nasrollahzadeh D; Roshandel G; Delhomme TM; Avogbe PH; Foll M; Saidi F; Poustchi H; Sotoudeh M; Malekzadeh R; Brennan P; Mckay J; Hainaut P; Abedi-Ardekani B
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073316
[TBL] [Abstract][Full Text] [Related]
7. An Old Story Retold: Loss of G1 Control Defines A Distinct Genomic Subtype of Esophageal Squamous Cell Carcinoma.
Wang Q; Bai J; Abliz A; Liu Y; Gong K; Li J; Shi W; Pan Y; Liu F; Lai S; Yang H; Lu C; Zhang L; Chen W; Xu R; Cai H; Ke Y; Zeng C
Genomics Proteomics Bioinformatics; 2015 Aug; 13(4):258-70. PubMed ID: 26386145
[TBL] [Abstract][Full Text] [Related]
8. Mutational profile of TP53 in esophageal squamous cell carcinoma associated with chagasic megaesophagus.
Lacerda CF; Cruvinel-Carloni A; de Oliveira AT; Scapulatempo-Neto C; López RV; Crema E; Adad SJ; Rodrigues MA; Henry MA; Guimarães DP; Reis RM
Dis Esophagus; 2017 Apr; 30(4):1-9. PubMed ID: 28375484
[TBL] [Abstract][Full Text] [Related]
9. Genetic Alterations in Esophageal Tissues From Squamous Dysplasia to Carcinoma.
Liu X; Zhang M; Ying S; Zhang C; Lin R; Zheng J; Zhang G; Tian D; Guo Y; Du C; Chen Y; Chen S; Su X; Ji J; Deng W; Li X; Qiu S; Yan R; Xu Z; Wang Y; Guo Y; Cui J; Zhuang S; Yu H; Zheng Q; Marom M; Sheng S; Zhang G; Hu S; Li R; Su M
Gastroenterology; 2017 Jul; 153(1):166-177. PubMed ID: 28365443
[TBL] [Abstract][Full Text] [Related]
10. Anterior gradient 2 regulates cancer progression in
Takabatake K; Konishi H; Arita T; Kataoka S; Shibamoto J; Furuke H; Takaki W; Shoda K; Shimizu H; Yamamoto Y; Komatsu S; Shiozaki A; Fujiwara H; Okamoto K; Otsuji E
Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34713298
[TBL] [Abstract][Full Text] [Related]
11. Clonal evolution of esophageal squamous cell carcinoma from normal mucosa to primary tumor and metastases.
Yuan W; Liu Z; Wang Y; Liu M; Pan Y; Lei W; Yang H; Xu R; Zhang L; Cai H; Li J; Ke Y
Carcinogenesis; 2019 Dec; 40(12):1445-1451. PubMed ID: 31570939
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological and mutational analysis of esophageal basaloid squamous cell carcinoma.
Yanai Y; Hayashi T; Tsuyama S; Nasu M; Hashimoto T; Kajiyama Y; Tsurumaru M; Mine S; Orita H; Fukunaga T; Yao T; Saito T
Virchows Arch; 2022 Sep; 481(3):477-487. PubMed ID: 35641667
[TBL] [Abstract][Full Text] [Related]
13. Whole-exome sequencing reveals critical genes underlying metastasis in oesophageal squamous cell carcinoma.
Dai W; Ko JMY; Choi SSA; Yu Z; Ning L; Zheng H; Gopalan V; Chan KT; Lee NP; Chan KW; Law SY; Lam AK; Lung ML
J Pathol; 2017 Aug; 242(4):500-510. PubMed ID: 28608921
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive mutational analysis of background mucosa in patients with Lugol-voiding lesions.
Akizue N; Okimoto K; Arai M; Hirotsu Y; Amemiya K; Oura H; Kaneko T; Tokunaga M; Ishikawa K; Ohta Y; Taida T; Saito K; Maruoka D; Matsumura T; Nakagawa T; Nishimura M; Chiba T; Matsushita K; Mochizuki H; Yokosuka O; Omata M; Kato N
Cancer Med; 2021 Jun; 10(11):3545-3555. PubMed ID: 33934524
[TBL] [Abstract][Full Text] [Related]
15. P53-regulated lncRNA uc061hsf.1 inhibits cell proliferation and metastasis in human esophageal squamous cell cancer.
Yao J; Zhang H; Li H; Qian R; Liu P; Huang J
IUBMB Life; 2020 Mar; 72(3):401-412. PubMed ID: 31743955
[TBL] [Abstract][Full Text] [Related]
16. Hypomethylation-Linked Activation of PLCE1 Impedes Autophagy and Promotes Tumorigenesis through MDM2-Mediated Ubiquitination and Destabilization of p53.
Chen Y; Xin H; Peng H; Shi Q; Li M; Yu J; Tian Y; Han X; Chen X; Zheng Y; Li J; Yang Z; Yang L; Hu J; Huang X; Liu Z; Huang X; Zhou H; Cui X; Li F
Cancer Res; 2020 Jun; 80(11):2175-2189. PubMed ID: 32066565
[TBL] [Abstract][Full Text] [Related]
17. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China.
Hu N; Huang J; Emmert-Buck MR; Tang ZZ; Roth MJ; Wang C; Dawsey SM; Li G; Li WJ; Wang QH; Han XY; Ding T; Giffen C; Goldstein AM; Taylor PR
Clin Cancer Res; 2001 Apr; 7(4):883-91. PubMed ID: 11309337
[TBL] [Abstract][Full Text] [Related]
18. miR612 is associated with esophageal squamous cell carcinoma development and metastasis, mediated through TP53.
Zhou P; Dong H; He S; Fang L; Jiang N; Sun Q
Mol Med Rep; 2017 Aug; 16(2):1855-1863. PubMed ID: 28656264
[TBL] [Abstract][Full Text] [Related]
19. Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2.
Zhou X; Li Y; Wang W; Wang S; Hou J; Zhang A; Lv B; Gao C; Yan Z; Pang D; Lu K; Ahmad NH; Wang L; Zhu J; Zhang L; Zhuang T; Li X
Theranostics; 2020; 10(21):9443-9457. PubMed ID: 32863938
[No Abstract] [Full Text] [Related]
20. The differences of immunologic and TP53 mutant phenotypes between synchronous and metachronous head and neck cancer and esophageal cancer.
Chen TC; Wu CT; Wang CP; Lou PJ; Ko JY; Chang YL
Oral Oncol; 2020 Dec; 111():104945. PubMed ID: 32769036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
